-
Research HighlightJanuary 18, 2021JAX uses genetic models to fight CUP
A JAX team developed CUP-AI-Dx, a machine learning tool that uses RNA sequence data for analysis. The researchers show that CUP-AI-Dx provides an important clinical tool to help guide therapies for CUP patients. -
Press ReleaseJanuary 07, 2021Using the mouse model to fight against heart attacks
British Heart Foundation funds research aimed at supporting the lymphatic system to prevent heart failure. -
Research HighlightNovember 20, 2020Researchers at JAX developing new CRS tool
JAX researchers are developing a valuable new cytokine release syndrome research tool. -
Research HighlightNovember 10, 2020Alternative RNA splicing: The 'special effects' editing of gene expression
Olga Anczukow describes a network of regulation for splicing factors, key proteins for controlling protein production. Dysfunction can cause a variety of diseases, including cancer.
-
Research HighlightJanuary 12, 2021Few mutations, important difference in cancer cells
JAX Professor Sheng Li, Ph.D., presents a tool, epihet, that automates the epigenetic analysis of AML cells. epihet allows researchers to assess epigenetic differences between cells, identify genomic locations where the differences occur, and associate cellular epigenetic profiles with cancer-related biological function. -
Research HighlightDecember 12, 2020JAX pioneers way to analyze cancer image data
A team led by JAX Associate Professor Jeffrey Chuang, Ph.D., has developed image processing and convolutional neural network software that can combine images of cancers from different organs to reveal how they are related to one another. -
Blog PostNovember 18, 2020Revealing treatment options with category variants
-
Press ReleaseNovember 05, 2020Genomic testing in the U.S. workplace
Employee perk or privacy hazard? NIH funds JAX-co-led study to explore the ethical, legal, social, policy implications.